Clinical Trials Logo

Filter by:
NCT ID: NCT04643925 Completed - Infertility, Female Clinical Trials

hCG Priming in Women With Low Ovarian Reserve

Start date: December 27, 2020
Phase: Phase 4
Study type: Interventional

The aim of this trial is to examine the possible effects of hCG administration for eight weeks prior to IVF/ICSI in women with low ovarian reserve. Primary outcome is the proportion of the antral follicle count that reach the pre-ovulatory stage.

NCT ID: NCT04642768 Completed - Cardiogenic Shock Clinical Trials

Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic Shock

KETO-SHOCK1
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Background Cardiogenic shock is a life-threatening state of acute heart failure with severely depressed blood pressure and organ perfusion. The 30-day mortality is reported as high as 50%. To date, no randomized trial has documented a survival benefit of any medical treatment in this patient group. In a first-in-man study the investigators have recently discovered that treatment with ketone bodies increases cardiac output by 2 liters per minute. Objective The present study aims to examine the direct effects of ketone body supplements on the heart function in patients hospitalized with cardiogenic shock. Also, the aim is to determine the relative need for medical circulatory support following ketone body supplement. Design A randomized double-blind cross-over study of the hemodynamic effect of enteral ketone ester versus placebo in 12 patients with cardiogenic shock Methods Right heart catheterization will be installed to monitor cardiac pressures and output. The investigators will observe heart function with transthoracic echocardiography. Blood- and urine samples will be analyzed for electrolytes, energy substrates and vasoactive substances. Organ perfusion is to be examined by renal ultrasonography and near-infrared spectroscopy for measuring cerebral and peripheral circulation. Perspectives This investigation may grant essential knowledge on ketosis in cardiogenic shock. This may lead to larger clinical trials, and hopefully a new and better treatment for patients with cardiogenic shock.

NCT ID: NCT04642365 Completed - Solid Tumors Clinical Trials

A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.

Start date: January 4, 2021
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability and preliminary anti-tumor activity of RO7296682 in combination with Atezolizumab in participants with advanced solid tumors.

NCT ID: NCT04641299 Completed - Dyslipidaemia Clinical Trials

A Study of AZD8233 in Participants With Dyslipidemia

Start date: October 28, 2020
Phase: Phase 2
Study type: Interventional

AZD8233 is a PCSK9-targeted ASO for the reduction of circulating levels of LDL-C. This study aims to evaluate the dose-dependent reduction in LDL-C after SC administration of multiple doses of AZD8233 as well as the associated adverse effects profile. The data generated will be used to guide choice of doses, dosing regimens, and sample sizes, as well as safety and PD monitoring in the further clinical development program.

NCT ID: NCT04640415 Completed - Clinical trials for Complication,Postoperative

Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Postsurgical Patient Deterioration.

WARD-RCT-SX
Start date: January 11, 2021
Phase: N/A
Study type: Interventional

The primary aim of the current study is to assess the effect of continuous wireless vital sign monitoring with generation of real-time alerts, compared to blinded monitoring without alerts on the cumulative duration of any severely deviating vital signs in patients admitted to general hospital wards after major surgery. We hypothesize that continuous vital signs monitoring, and real-time alerts will reduce the cumulative duration of severely deviating vital signs.

NCT ID: NCT04639167 Completed - Clinical trials for Mental Health Disorder

Paths to Everyday Life - a Community-based Peer Support Intervention

PEER
Start date: December 7, 2020
Phase: N/A
Study type: Interventional

The aim of this randomized, two-arm, investigator initiated, multi municipal, parallel-group superiority trial is to compare the effect on self-reported personal recovery of the following interventions: (1) 10-week group-based peer support intervention "Paths to everyday life" (PEER) added to service as usual (SAU); and (2) SAU alone. The primary outcome is self-reported personal recovery at end of intervention. Secondary and exploratory measures include empowerment, quality of life, functioning, hope, self-efficacy, self-advocacy and social network. The investigators, hypothesize that the superiority of the PEER intervention will be applicable for secondary outcomes and exploratory measures at end of intervention so that improvement in empowerment, hope, self-efficacy, self-advocacy, social network, quality of life and functioning will be improved among participants allocated to the PEER intervention.

NCT ID: NCT04638608 Completed - Clinical trials for Cognitive Impairment

A Complex Intervention Study on a Palliative Rehabilitation Blended Learning Program to Support Relatives and Health Care Providers of People With ALS and Cognitive Impairments in Coping With Challenges

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

A complex intervention study on a palliative rehabilitation blended learning program to support relatives and health care providers of people with ALS and cognitive impairments in coping with challenges.

NCT ID: NCT04635670 Completed - Type 1 Diabetes Clinical Trials

Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes

ProFOS
Start date: June 29, 2020
Phase: N/A
Study type: Interventional

The primary objective is to assess the impact of three months' treatment with pre-/probiotic mix on markers of nephropathy and other comorbidity related to diabetes. A double blinded, randomized, placebo-controlled crossover, single-centre study including 46 patients with type 1 diabetes and albuminuria. The treatment period is 2 x 12 weeks with 6 weeks washout. The primary outcome is to evaluate the effect of pre-/probiotic mix on albuminuria.

NCT ID: NCT04635254 Completed - Pain, Acute Clinical Trials

The Effect of Halophyte-based Cream on Pain and Itch

Start date: November 12, 2020
Phase: N/A
Study type: Interventional

In this study the investigators wish to investigate whether halophyte-based cream applied to the skin can reduce itch applied by means of small needles from the plant mucuna pruriens (also called cowhage) or by histamine (an itch-evoking substance formed in the human body). Further, the investigators wishes to investigate whether long-term application of halophyte-based cream has a pain-relieving effect on heat/cold and pinprick stimulations.

NCT ID: NCT04633850 Completed - Lung Cancer Clinical Trials

Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients

Start date: September 8, 2020
Phase:
Study type: Observational

To investigate the effect of intercostal blockade with and without adjuvants.